Articles related to SCHIZOPHRENIA
Study Shows Weekly Oral Risperidone Comparable to Daily Doses for Schizophrenia
LYN-005 represents a breakthrough in schizophrenia management, showing promise in maintaining therapeutic levels and symptom control with just once-weekly dosing.
Psychiatry February 21st 2024
Alternative Approaches for Addressing Acute Agitation in Schizophrenia and Bipolar Disorder
Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.
Psychiatry February 13th 2024
Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study
The JEWEL study has demonstrated that lurasidone treatment in patients with schizophrenia results in significant improvements in social functioning, with notable progress observed from the early stages of treatment and sustained benefits over a 12-week extension period.
Neurology February 13th 2024
Cat Ownership Associated with Increased Risk for Schizophrenia-Related Disorders
This meta-analysis highlights a significant association between cat ownership and an increased risk of schizophrenia-related disorders, emphasizing the need for further exploration of environmental factors in mental health.
Psychiatry January 23rd 2024
FDA Drug Approval Decisions Expected in February 2024
Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.
Hematology/Oncology January 22nd 2024